sevoflurane has been researched along with Acute Post-Traumatic Stress Disorder in 3 studies
Sevoflurane: A non-explosive inhalation anesthetic used in the induction and maintenance of general anesthesia. It does not cause respiratory irritation and may also prevent PLATELET AGGREGATION.
sevoflurane : An ether compound having fluoromethyl and 1,1,1,3,3,3-hexafluoroisopropyl as the two alkyl groups.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Posttraumatic stress disorder (PTSD) is a persistent and severe psychological and mental disorder resulting from experiences of serious trauma or stress and is suffered by many individuals." | 1.91 | Sevoflurane Preconditioning Alleviates Posttraumatic Stress Disorder-Induced Apoptosis in the Hippocampus via the EZH2-Regulated Akt/mTOR Axis and Improves Synaptic Plasticity. ( Gao, D; Gu, T; Jiang, G; Liu, Q; Meng, X; Xu, C; Yin, A; Zhang, L, 2023) |
| "Post-traumatic stress disorder (PTSD) is a psychiatric disease that may occur after intense psychological trauma or physiological stress." | 1.42 | Sevoflurane attenuates stress-enhanced fear learning by regulating hippocampal BDNF expression and Akt/GSK-3β signaling pathway in a rat model of post-traumatic stress disorder. ( Chen, C; Ji, M; Li, W; Liu, J; Sun, Q; Xu, Q; Zhang, Y; Zhu, S, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Qing, X | 1 |
| Xu, YL | 1 |
| Liu, H | 1 |
| Liu, XS | 1 |
| Gu, T | 1 |
| Xu, C | 1 |
| Meng, X | 1 |
| Gao, D | 1 |
| Jiang, G | 1 |
| Yin, A | 1 |
| Liu, Q | 1 |
| Zhang, L | 1 |
| Chen, C | 1 |
| Ji, M | 1 |
| Xu, Q | 1 |
| Zhang, Y | 1 |
| Sun, Q | 1 |
| Liu, J | 1 |
| Zhu, S | 1 |
| Li, W | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Subanesthetic Sevoflurane for Treatment-Resistant Depression: A Proof-of-Concept Trial[NCT05008939] | 15 participants (Anticipated) | Interventional | 2021-08-31 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 other studies available for sevoflurane and Acute Post-Traumatic Stress Disorder
| Article | Year |
|---|---|
The influence of anesthesia and surgery on fear extinction.
Topics: Anesthesia; Anesthetics; Animals; Anti-Inflammatory Agents; Dexmedetomidine; Extinction, Psychologic | 2022 |
Sevoflurane Preconditioning Alleviates Posttraumatic Stress Disorder-Induced Apoptosis in the Hippocampus via the EZH2-Regulated Akt/mTOR Axis and Improves Synaptic Plasticity.
Topics: Animals; Apoptosis; Enhancer of Zeste Homolog 2 Protein; Hippocampus; Neuronal Plasticity; Proto-Onc | 2023 |
Sevoflurane attenuates stress-enhanced fear learning by regulating hippocampal BDNF expression and Akt/GSK-3β signaling pathway in a rat model of post-traumatic stress disorder.
Topics: Animals; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Fear; Glycogen Synthase Kinase 3 | 2015 |